• Home
  • Search Results

Search Results

402 studies match your search
Open

Study of RP1 in Organ and Cell Transplant Patients With Skin Cancer

Have you had an organ transplant or hematopoietic cell transplant and have advanced cutaneous squamous cell carcinoma? If so, you might be eligible to take part in a study to see if an investigation drug, RP1, can help treat your skin cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Other Cancers)
Open

Study for Patients with Non-small Cell Lung Cancer

Have you been diagnosed with Stage III non-small cell lung cancer? Is your cancer advanced and not able to to removed? If so, you might be able to participate in a study that looks at a study drug to see if it can help the radiation treatment work better against your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung)
Open

The ARC Study

Help us advance research for cerebellum disorders! The ARC Study (Advancing Research for Cerebellum Disorders using 3T & 7T MRI) is currently looking for healthy participants to participate in a research study involving brain MRI scans. Participants can earn up to $100 in giftcards for participation.

Age & Gender
  • 14 years ~ 21 years
  • Female
Study Interest
  • Brain, Head, Nervous System
  • Developmental
  • Healthy Volunteer or General Population
  • UNC Students (undergrad, grad, professional)
Open

Pediatric Ravulizumab Study

This is a research study for pediatric patients previously been diagnosed with generalized myasthenia gravis (gMG) which is a condition that causes abnormalities of your immune system which may lead to generalized muscle weakness. This study looks at an investigational drug called ravulizumab (referred to as "study drug") to treat gMG by blocking complement activity that fights against infections. Although ravulizumab is approved to treat gMG in adults, in this study, ravulizumab is considered an experimental drug, which means it is not approved for use in treating children with gMG in any country at this time.

Age & Gender
  • 6 years ~ 17 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Chronic Conditions
Open

Liver Cancer Screening Study

If you have liver cirrhosis or chronic hepatitis B infection, you may qualify to participate in a research study that compares the effectiveness of two liver cancer screening methods. Please contact the study team to get more information. Compensation provided.

Age & Gender
  • 18 years ~ 85 years
  • Male, Female, Gender Inclusive
Study Interest
  • Stomach, Digestion and Gut Health
Open

A study to compare two surgical procedures in individuals with BRCA1 mutations to assess reduced risk of ovarian cancer

Do you have BRCA1 mutation and have elected to undergo a surgical intervention? If so, you may be able to take part in a research study comparing two surgical procedures and their ability to decrease the risk of developing ovarian cancer.

Age & Gender
  • 35 years ~ 50 years
  • Female
Study Interest
  • Cancer (Ovarian)
Open

PRevention Of Frailty with Fisetin (PROFFi) in Breast Cancer Survivors

Are you a breast cancer survivor? if soy you may be eligible to participate in this research study that is looking at the effectiveness of fisetin and/or exercise on physical function assessed using a 6 minute walking distance in chemotherapy-treated postmenopausal breast cancer survivors

Age & Gender
  • 18 years ~ 70 years
  • Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Multicohort, Phase 1/2 Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors

Do you have With Locally Advanced or Metastatic Solid Tumors of the Head or Neck? If so, you may be able to participate in a research study to to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of INBRX 106 administered as a single agent or in combination with the anti-PD-1 checkpoint inhibitor (CPI) pembrolizumab (Keytruda®).

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Open

Immune Functioning and Social Reward Processing in Autism and Typical Development

Are you interested in learning more about how the body and brain influences social behavior? If you are between 18 and 29 years old, you may be eligible to participate in our new EEG study! This project uses EEG and blood assaying techniques to understand how differences in immune functioning relates to the way that reward is processed in the brain. Compensation is provided.

Age & Gender
  • 18 years ~ 29 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
  • Immune System/Infections
  • UNC or UNC Health employees
  • and 3 more
Open

Hydrolyzed Formula in Infants and Children with Cow's Milk Allergy

The purpose of this study is to determine if an extensively broken-down milk protein formula is safe for children with cow's milk protein allergy.

Age & Gender
  • 3 months ~ 12 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research